Stocks and Investing
Stocks and Investing
Mon, November 21, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ami Fadia Maintained (AVDL) at Strong Buy with Increased Target to $9 on, Nov 21st, 2022
Ami Fadia of Needham, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $8 to $9 on, Nov 21st, 2022.
Ami has made no other calls on AVDL in the last 4 months.
There are 2 other peers that have a rating on AVDL. Out of the 2 peers that are also analyzing AVDL, 1 agrees with Ami's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Increased Target to $8 on, Wednesday, August 10th, 2022
This is the rating of the analyst that currently disagrees with Ami
- Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $12 on, Thursday, August 11th, 2022
Contributing Sources